{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:11:23Z","timestamp":1778821883460,"version":"3.51.4"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>The cardiac ryanodine receptor (RyR2) is a critical calcium release channel essential for normal cardiac contraction. Dysregulation of RyR2 function is a key pathogenic factor in various cardiac diseases, notably arrhythmias and heart failure. The clinical spectrum of RyR2-related diseases (ryanodinopathy) has expanded beyond the well-established gain-of-function (GOF) mutations causing catecholaminergic polymorphic ventricular tachycardia (CPVT). Recent research has now delineated two additional distinct clinical entities: exon 3 deletion syndrome (E3DS), which presents with CPVT along with structural abnormalities, and calcium release deficiency syndrome (CRDS), caused by loss-of-function (LOF) mutations. CRDS is characterized by impaired calcium release from the sarcoplasmic reticulum and fundamentally differs from the classical CPVT phenotype, necessitating distinct approaches to its diagnosis, clinical management, and therapeutic intervention. This review provides a comprehensive overview of the current understanding of CRDS. We discuss its clinical manifestations, scrutinize the underlying molecular mechanisms, evaluate available diagnostic strategies, and explore potential therapeutic avenues. By synthesizing latest findings, this review aims to illuminate the complexities of RyR2-mediated pathologies and foster further progress in this evolving field.<\/jats:p>","DOI":"10.3389\/fmolb.2026.1810279","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:27:47Z","timestamp":1778819267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Calcium release deficiency syndrome: an emerging ryanodinopathy"],"prefix":"10.3389","volume":"13","author":[{"given":"Kaiyang","family":"Gao","sequence":"first","affiliation":[{"name":"School of Medicine, Northwest University","place":["Xi\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Tao","sequence":"additional","affiliation":[{"name":"School of Medicine, Northwest University","place":["Xi\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Li","sequence":"additional","affiliation":[{"name":"School of Medicine, Northwest University","place":["Xi\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baihe","family":"Li","sequence":"additional","affiliation":[{"name":"School of Medicine, Northwest University","place":["Xi\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nike","family":"Li","sequence":"additional","affiliation":[{"name":"School of Medicine, Northwest University","place":["Xi\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhong","family":"Wei","sequence":"additional","affiliation":[{"name":"School of Medicine, Northwest University","place":["Xi\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/cvr\/cvt024","article-title":"Ryanopathy\u2019: causes and manifestations of RyR2 dysfunction in heart failure","volume":"98","author":"Belevych","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation\u2013contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.107.711606","article-title":"Expanding spectrum of human RYR2 -Related disease: new electrocardiographic, structural, and genetic features","volume":"116","author":"Bhuiyan","year":"2007","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/jpm11060579","article-title":"A type 2 ryanodine receptor variant in the helical domain 2 associated with an impairment of the adrenergic response","volume":"11","author":"Blancard","year":"2021","journal-title":"JPM"},{"key":"B5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pop.2023.07.008","article-title":"Arrhythmias and sudden cardiac death","volume":"51","author":"Bragg","year":"2024","journal-title":"Prim. Care Clin. Office Pract."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e009634","DOI":"10.1161\/CIRCHEARTFAILURE.122.009634","article-title":"Role of implantable cardioverter defibrillator in heart failure with contemporary medical therapy","volume":"15","author":"Butler","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e013757","DOI":"10.1161\/CIRCEP.124.013757","article-title":"RYR2 variants in catecholaminergic polymorphic ventricular tachycardia patients: insights from protein structure and clinical data","volume":"18","author":"Chang","year":"2025","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"H1703","DOI":"10.1152\/ajpheart.00310.2002","article-title":"Premature excitation and onset of reentrant ventricular tachycardia","volume":"283","author":"Ciaccio","year":"2002","journal-title":"Am. J. Physiology-Heart Circulatory Physiology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1093\/eurheartj\/ehad418","article-title":"Clinical presentation of calmodulin mutations: the international calmodulinopathy registry","volume":"44","author":"Crotti","year":"2023","journal-title":"Eur. Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"euad301","DOI":"10.1093\/europace\/euad301","article-title":"Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter-defibrillator","volume":"25","author":"Crozier","year":"2023","journal-title":"Europace"},{"key":"B11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev-pharmtox-061724-080739","article-title":"Inhibitors of intracellular RyR2 calcium release channels as therapeutic agents in arrhythmogenic heart diseases","volume":"65","author":"Do","year":"2025","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and excitation-contraction coupling in the heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circulation Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1113\/JP273714","article-title":"Calcium\u2010calmodulin\u2010dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance","volume":"595","author":"Federico","year":"2017","journal-title":"J. Physiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1152\/physrev.00013.2002","article-title":"Ryanodine receptor calcium release channels","volume":"82","author":"Fill","year":"2002","journal-title":"Physiol. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.hrthm.2016.10.015","article-title":"A type 2 ryanodine receptor variant associated with reduced Ca2+ release and short-coupled torsades de pointes ventricular arrhythmia","volume":"14","author":"Fujii","year":"2017","journal-title":"Heart Rhythm"},{"key":"B17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-019-1377-y","article-title":"Modulation of cardiac ryanodine receptor 2 by calmodulin","volume":"572","author":"Gong","year":"2019","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10110","DOI":"10.1038\/s41467-025-65096-1","article-title":"Crystal structures of ryanodine receptor reveal dantrolene and azumolene interactions guiding inhibitor development","volume":"16","author":"Hadiatullah","year":"2025","journal-title":"Nat. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/europace\/euab250","article-title":"Loss-of-function mutations in cardiac ryanodine receptor channel cause various types of arrhythmias including long QT syndrome","volume":"24","author":"Hirose","year":"2022","journal-title":"EP Eur."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e15265","DOI":"10.14814\/phy2.15265","article-title":"Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling","volume":"10","author":"Hopton","year":"2022","journal-title":"Physiol. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"18309","DOI":"10.1073\/pnas.0706573104","article-title":"Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death","volume":"104","author":"Jiang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00204-022-03385-0","article-title":"Role of Ca2+ in healthy and pathologic cardiac function: from normal excitation\u2013contraction coupling to mutations that cause inherited arrhythmia","volume":"97","author":"Keefe","year":"2023","journal-title":"Arch. Toxicol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1113\/JP277827","article-title":"Dynamic clamping human and rabbit atrial calcium current: narrowing ICaL window abolishes early afterdepolarizations","volume":"597","author":"Kettlewell","year":"2019","journal-title":"J. Physiology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijcard.2015.08.044","article-title":"Recurrent ventricular fibrillation in a young female carrying a previously unidentified RyR2 gene mutation","volume":"201","author":"Kron","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/CIRCRESAHA.120.316819","article-title":"RYR2 channel inhibition is the principal mechanism of flecainide action in CPVT","volume":"128","author":"Kryshtal","year":"2021","journal-title":"Circulation Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbrep.2017.01.002","article-title":"Flecainide ameliorates arrhythmogenicity through NCX flux in andersen-Tawil syndrome-iPS cell-derived cardiomyocytes","volume":"9","author":"Kuroda","year":"2017","journal-title":"Biochem. Biophysics Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e010013","DOI":"10.1161\/CIRCEP.121.010013","article-title":"Human RyR2 (Ryanodine receptor 2) loss-of-function mutations: clinical phenotypes and in vitro characterization","volume":"14","author":"Li","year":"2021","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1161\/CIRCRESAHA.111.247338","article-title":"Short communication: Flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity","volume":"109","author":"Liu","year":"2011","journal-title":"Circulation Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.str.2011.03.016","article-title":"The deletion of exon 3 in the cardiac ryanodine receptor is rescued by \u03b2 strand switching","volume":"19","author":"Lobo","year":"2011","journal-title":"Structure"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e019273","DOI":"10.1161\/JAHA.120.019273","article-title":"Acute genetic ablation of cardiac sodium\/calcium exchange in adult mice: implications for cardiomyocyte calcium regulation, cardioprotection, and arrhythmia","volume":"10","author":"Lotteau","year":"2021","journal-title":"JAHA"},{"key":"B77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2350-10-12","article-title":"Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia","volume":"10","author":"Marjamaa","year":"2009","journal-title":"BMC Med. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e162891","DOI":"10.1172\/JCI162891","article-title":"Targeting ryanodine receptors to treat human diseases","volume":"133","author":"Marks","year":"2023","journal-title":"J. Clin. Investigation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.jacc.2009.08.022","article-title":"The RYR2-Encoded ryanodine receptor\/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome","volume":"54","author":"Medeiros-Domingo","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8080","DOI":"10.1038\/s41467-024-51791-y","article-title":"Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders","volume":"15","author":"Miotto","year":"2024","journal-title":"Nat. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/biom12030377","article-title":"Intracellular Ca2+-Mediated mechanisms for the pacemaker depolarization of the mouse and Guinea pig sinus node tissue","volume":"12","author":"Namekata","year":"2022","journal-title":"Biomolecules"},{"key":"B36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/CIRCRESAHA.123.322504","article-title":"Increased Ca2+ transient underlies RyR2-Related left ventricular noncompaction","volume":"133","author":"Ni","year":"2023","journal-title":"Circulation Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jama.2024.8599","article-title":"A clinical diagnostic test for calcium release deficiency syndrome","volume":"332","author":"Ni","year":"2024","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.hrthm.2011.05.016","article-title":"Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene","volume":"8","author":"Nof","year":"2011","journal-title":"Heart Rhythm"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e003589","DOI":"10.1161\/CIRCGEN.121.003589","article-title":"Provocation testing and therapeutic response in a newly described channelopathy: RyR2 calcium release deficiency syndrome","volume":"15","author":"Ormerod","year":"2022","journal-title":"Circ. Genomic Precis. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00246-014-0950-2","article-title":"Ryanodine receptor mutations presenting as idiopathic ventricular fibrillation: a report on two novel familial compound mutations, c.6224T>C and c.13781A>G, with the clinical presentation of idiopathic ventricular fibrillation","volume":"35","author":"Paech","year":"2014","journal-title":"Pediatr. Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"aah5324","DOI":"10.1126\/science.aah5324","article-title":"Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/CIRCRESAHA.110.226845","article-title":"Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis","volume":"108","author":"Priori","year":"2011","journal-title":"Circulation Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.jacc.2020.12.073","article-title":"Precision medicine in catecholaminergic polymorphic ventricular tachycardia","volume":"77","author":"Priori","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/CIRCRESAHA.122.321668","article-title":"Cardiac alternans: from bedside to bench and back","volume":"132","author":"Qu","year":"2023","journal-title":"Circulation Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.hrthm.2021.04.007","article-title":"Flecainide-induced QRS complex widening correlates with negative inotropy","volume":"18","author":"Rab\u00ealo Evangelista","year":"2021","journal-title":"Heart Rhythm"},{"key":"B48","doi-asserted-by":"publisher","first-page":"H1137","DOI":"10.1152\/ajpheart.00439.2022","article-title":"Guidelines for assessment of cardiac electrophysiology and arrhythmias in small animals","volume":"323","author":"Ripplinger","year":"2022","journal-title":"Am. J. Physiology-Heart Circulatory Physiology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jelectrocard.2016.09.006","article-title":"A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia","volume":"50","author":"Roston","year":"","journal-title":"J. Electrocardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.hrthm.2016.11.004","article-title":"Suppression-of-function mutations in the cardiac ryanodine receptor: emerging evidence for a novel arrhythmia syndrome?","volume":"14","author":"Roston","year":"","journal-title":"Heart Rhythm"},{"key":"B51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/jamacardio.2021.4458","article-title":"Clinical and functional characterization of ryanodine receptor 2 variants implicated in calcium-release deficiency syndrome","volume":"7","author":"Roston","year":"2022","journal-title":"JAMA Cardiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e202213089","DOI":"10.1085\/jgp.202213089","article-title":"How does flecainide impact RyR2 channel function?","volume":"154","author":"Salvage","year":"2022","journal-title":"J. General Physiology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/europace\/euab283","article-title":"Cardiac ryanodine receptors: is a severe loss-of-function not so severe after all?","volume":"24","author":"Santiago","year":"2022","journal-title":"EP Eur."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1038\/s41467-024-47850-z","article-title":"Cardiac function is regulated by the sodium-dependent inhibition of the sodium-calcium exchanger NCX1","volume":"15","author":"Scranton","year":"2024","journal-title":"Nat. Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e017128","DOI":"10.1161\/JAHA.120.017128","article-title":"Novel RyR2 mutation (G3118R) is associated with autosomal recessive ventricular fibrillation and sudden death: clinical, functional, and computational analysis","volume":"10","author":"Shauer","year":"2021","journal-title":"JAHA"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.hrthm.2024.07.012","article-title":"Top stories on intracellular potassium channels in cardiac arrhythmia","volume":"21","author":"Singh","year":"2024","journal-title":"Heart Rhythm"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e1012635","DOI":"10.1371\/journal.pcbi.1012635","article-title":"Mechanism of arrhythmogenesis driven by early after depolarizations in cardiac tissue","volume":"21","author":"Stein","year":"2025","journal-title":"PLoS Comput. Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"euad156","DOI":"10.1093\/europace\/euad156","article-title":"RYR2-ryanodinopathies: from calcium overload to calcium deficiency","volume":"25","author":"Steinberg","year":"2023","journal-title":"Europace"},{"key":"B59","doi-asserted-by":"publisher","first-page":"eaba7287","DOI":"10.1126\/scitranslmed.aba7287","article-title":"Cardiac ryanodine receptor calcium release deficiency syndrome","volume":"13","author":"Sun","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.mayocp.2012.02.017","article-title":"Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing","volume":"87","author":"Tester","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e135952","DOI":"10.1172\/jci.insight.135952","article-title":"Molecular characterization of the calcium release channel deficiency syndrome","volume":"5","author":"Tester","year":"2020","journal-title":"JCI Insight"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1042\/BCJ20230254","article-title":"RyR2 C-terminal truncating variants identified in patients with arrhythmic phenotypes exert a dominant negative effect through formation of wildtype-truncation heteromers","volume":"480","author":"Tian","year":"2023","journal-title":"Biochem. J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/cvr\/cvae009","article-title":"The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies","volume":"120","author":"Tonko","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1093\/cvr\/cvab324","article-title":"SR-Mitochondria crosstalk shapes ca signalling to impact pathophenotype in disease models marked by dysregulated intracellular ca release","volume":"118","author":"Tow","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"JP288499","DOI":"10.1113\/JP288499","article-title":"Catecholaminergic polymorphic ventricular tachycardia\u2013linked ryanodine receptor variants exhibit domain\u2010specific calcium leak and calmodulin affinity properties","author":"Uchinoumi","year":"2025","journal-title":"J. Physiology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1152\/physrev.00024.2019","article-title":"Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior","volume":"101","author":"Varr\u00f3","year":"2021","journal-title":"Physiol. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/pace.13419","article-title":"Afterdepolarizations and triggered activity as a mechanism for clinical arrhythmias","volume":"41","author":"Wit","year":"2018","journal-title":"Pacing Clin. Electrophis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00018-026-06130-3","article-title":"MYBPC3 (c.194 C > T) mutation-mediated RyR2 dysfunction contributes to pathogenic phenotypes of DCM revealed by HiPSC modeling","volume":"83","author":"Xie","year":"2026","journal-title":"Cell. Mol. Life Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.3390\/ijms24043365","article-title":"Calcium handling in inherited cardiac diseases: a focus on catecholaminergic polymorphic ventricular tachycardia and hypertrophic cardiomyopathy","volume":"24","author":"Zaffran","year":"2023","journal-title":"IJMS"},{"key":"B70","doi-asserted-by":"publisher","first-page":"E1669","DOI":"10.1073\/pnas.1419795112","article-title":"Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B71","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yjmcc.2022.04.004","article-title":"Preserved cardiac performance and adrenergic response in a rabbit model with decreased ryanodine receptor 2 expression","volume":"167","author":"Zheng","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s44161-025-00693-3","article-title":"Preventing the phosphorylation of RyR2 at canonical sites reduces Ca2+ leak and promotes arrhythmia by reactivating the INa current","volume":"4","author":"Zheng","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1113\/JP286145","article-title":"Role of ryanodine receptor cooperativity in Ca2+\u2010wave\u2010mediated triggered activity in cardiomyocytes","volume":"602","author":"Zhong","year":"2024","journal-title":"J. Physiology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1042\/BCJ20160606","article-title":"Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact hearts","volume":"473","author":"Zhong","year":"2016","journal-title":"Biochem. J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"BSR20210209","DOI":"10.1042\/BSR20210209","article-title":"Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death","volume":"41","author":"Zhong","year":"2021","journal-title":"Biosci. Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"17351","DOI":"10.1038\/s41598-024-65249-0","article-title":"Lower diastolic tension may be indicative of higher proarrhythmic propensity in failing human cardiomyocytes","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1810279\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:27:49Z","timestamp":1778819269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1810279\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":75,"alternative-id":["10.3389\/fmolb.2026.1810279"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1810279","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"1810279"}}